NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CANC

Tema Oncology ETF

Jul 11 • 04:00PM ET

25.81

Dollar change -0.40
Percentage change -1.53	%

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	-3.89%	Total Holdings	50	Perf Week	1.69%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	AUM	68.08M	Perf Month	-0.65%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	NAV/sh		Perf Quarter	16.63%
Index	-	Average Maturity		Tags	-	Return% 10Y		52W High	29.85 -13.55%	Perf Half Y	2.60%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	20.10 28.44%	Perf YTD	6.18%
Active/Passive		Quant Type		Tags	-	Flows% 1M	-8.36%	Volatility	2.33% 2.41%	Perf Year	-5.45%
Dividend TTM	0.50 (1.93%)	ESG Type		Tags	-	Flows% 3M	-3.34%	ATR (14)	0.66	Perf 3Y	-
Dividend Ex-Date	Dec 11, 2024	Dividend Type		Sector/Theme		Flows% YTD	31.71%	RSI (14)	57.65	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.98	Perf 10Y	-
Expense	0.75%	Growth/Value		SMA20	2.38%	Flows% 3Y		Rel Volume	0.30	Prev Close	26.21
Inverse/Leveraged		Market Cap		SMA50	4.84%	Flows% 5Y		Avg Volume	17.95K	Price	25.81
IPO	Aug 16, 2023	Option/Short	No / Yes	SMA200	1.30%	Trades		Volume	5,405	Change	-1.53%

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your FINVIZ experience